SARS-CoV-2 getting into the brain;neurological phenotype of COVID-19,and management by nano-biotechnology
Ma?gorzata Kujawska1
Ebrahim Mostafavi2
Ajeet Kaushik3
1.Department of Toxicology,Poznan University of Medical Sciences,Poznań,Poland2.Stanford Cardiovascular Institute/Department of Medicine,Stanford University School of Medicine,Stanford,CA,USA3.NanoBioTech Laboratory,Health Systems Engineering,Department of Natural Sciences,Florida Polytechnic University,Lakeland,FL,USA
摘要：Human coronavirus infection getting into the brain:By February 2022,the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection,causing the coronavirus disease 2019(COVID-19)outbreak,has infected around 415 million people,and caused～5.8 million deaths worldwide(WHO, SARS-CoV-2 replicates during the infection,it undergoes genetic mutation to generate variants with varying characteristics and mutation frequencies.The emerging,over time,new variants that differ with transmissibility,immunity,and infection severity pose continuous challenges to established COVID-19 management strategies and regulations.Several SARS-CoV-2 variants such as Omicron(B.1.1.529),Delta(B.1.617.2),UK(B.1.17),South Africa(B.1.351),Brazil(P.1),and New York B.1.525-B.1.526 were detected worldwide and accelerated severity of COVID-19 pandemic(Figure 1A;McQuaid et al.,2021).
机标关键词：sars-cov-2covid-19managementbrainnanobiotechnologygettinginto
论文发表日期：2023-03-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：2( 519-520 )